Researchers can use messenger RNA to trigger the immune system to attack tumors. By stimulating cancer cells to produce a ...

Although heart cells and skin cells contain identical instructions for creating proteins encoded in their DNA, they're able ...

When pathogens enter our cells as part of an infection, our body will trigger a programmed cell death known as "pyroptosis" ...

People looking to lose weight and lower their blood sugar may someday be able to get a single injection that turns their ...

Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that preclinical data for PROTAC BCL6 degrader ...

Research indicates that high-quality schooling can compensate for genetic disparities in reading success, underscoring the ...

As we move into the final stretch of the year, stocks continue to grind higher, with the S&P 500 now up 16% year-to-date.

Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage biopharmaceutical company leveraging its proprietary RADR® artificial intelligence platform to transform oncology drug discovery and development, ...

Through its collaboration with Variational AI, Rakovina Therapeutics utilized the Enki™ generative AI platform to identify novel small-molecule candidates predicted to meet a defined target product ...

Going gray is an inevitable, and for many, undesirable, part of aging, but health-wise, it’s no bad thing – it could reflect ...

Reviewers viewed the targeting of TFAM as innovative and the study's conclusions as potentially important (especially the effects on inflammation). However, the lack of evidence for a direct effect of ...